Global Stock News

Syros Pharmaceuticals Is A Buy As New Trials Start

Article feature image

Syros Pharmaceuticals Is A Buy As New Trials Start

wildpixel/iStock via Getty Images
In the high risk/high reward world of small, clinical stage pharmaceutical companies, one of my favorites is Syros Pharmaceuticals (SYRS). Syros is focused on controlling gene expression as a potential cure for cancers….

Click here to view the original article.

Share this article

Scroll to Top